If you want to call me a geek, that's fine but you're at the end of a long, long queue. I worked out the math for how many pALS would need to participate in a clinical trial to have a valid random sample group. Spoiler alert: Lots.
I won't bore anyone with the formula, but I'll come clean on assumptions. I used a rough estimate that 50% of the total pALS wouldn't qualify for some reason. That leaves about 17,500 people for the total population of people from which to select a sample.
If we want to be 95% confident of our results, +-2.5%, about 1400 people need to be enrolled in a study. That number swells to 2400 if we want to be 99% confident.
So, FDA, what was the last ALS trial to enroll that number of patients? Let me answer that for you: it's never happened.
Be real scientists. There's only one way to get this many people to submit data: Grant conditional approval for Genervon GM6. Now.
Oysters, Scallops, Conches
We are created to have abundant, meaningful life. Life where joy, beauty and love abound even in the most tragic of circumstances.
Find out how in Shells: Sustained by Grace Within the Tempest.